Evidence map›Paper›PMID 27554471›Full record

ArticleDiabetes2016

Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1.

Brennan K Smith, Rebecca J Ford, Eric M Desjardins, Alex E Green, Meghan C Hughes, Vanessa P Houde, Emily A Day, Katarina Marcinko, Justin D Crane, Emilio P Mottillo and 4 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03816488 (Oral Peri-operative TIming of Metformin), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03816488 phase1withdrawnstarted 2023, after this paper: background citation

Oral Peri-operative TIming of Metformin (or) Salsalate to Improve Non-cardiac Surgery Glucose Control - A Placebo-Controlled Internal Feasibility Trial

Ran2023Enrolled0Registered outcomes5Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Hyperglycemia, Perioperative/Postoperative Complications, Salsalate to Improve Non-cardiac Surgery Glucose ControlArmsMetformin, Salsalate
PMID 26957107PMID 26417892PMID 20435798other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. MASH: the nexus of metabolism, inflammation, and fibrosis.The Journal of clinical investigation · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Targeting skeletal muscle mitochondrial health in obesity.Clinical science (London, England : 1979) · 2022
    Review
  17. Article
  18. A Relevant Wound-LikeFrontiers in microbiology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Brennan K SmithDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Rebecca J FordDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Eric M DesjardinsDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Alex E GreenDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Meghan C HughesMuscle Health Research Centre, School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
Vanessa P HoudeDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Emily A DayDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Katarina MarcinkoDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Justin D CraneDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Emilio P MottilloDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Christopher G R PerryMuscle Health Research Centre, School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
Bruce E KempProtein Chemistry and Metabolism, St Vincent's Institute and Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Mark A TarnopolskyDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Gregory R SteinbergDivision of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada gsteinberg@mcmaster.ca.
McMaster University · CAYork University · CAAustralian Catholic University · AU

Funding

CIHR 114880-1CIHR 91634-2
6 · The paper itself

Abstract

Salsalate is a prodrug of salicylate that lowers blood glucose in patients with type 2 diabetes (T2D) and reduces nonalcoholic fatty liver disease (NAFLD) in animal models; however, the mechanism mediating these effects is unclear. Salicylate directly activates AMPK via the β1 subunit, but whether salsalate requires AMPK-β1 to improve T2D and NAFLD has not been examined. Therefore, wild-type (WT) and AMPK-β1-knockout (AMPK-β1KO) mice were treated with a salsalate dose resulting in clinically relevant serum salicylate concentrations (∼1 mmol/L). Salsalate treatment increased VO

Indexed as

AMP-Activated Protein KinasesAnimalsDiet, High-FatHepatocytesHomeostasisLipid MetabolismLipogenesisLiverMembrane Potential, MitochondrialMiceMice, KnockoutMitochondriaSalicylatesAMP-Activated Protein KinasesSalicylatessalicylsalicylic acid

Identifiers

PMID27554471
PMCPMC5233442
OpenAlexW2518640581

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.